Equity Capital Markets

Company · CIK 1579428

Axsome Therapeutics, Inc.

CIK1579428 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressNY
ListedAXSM (Nasdaq)
First annual or quarterly report2016-03-24

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291228
ShelfEffective
 2025-11-032025-11-031
333-268664
ShelfEffective
 2022-12-022023-06-293
333-235372
ShelfEffective
 2019-12-052022-08-225
333-214859
ShelfEffective
 2016-12-012019-05-098
333-207393
IPOFinal prospectus
 2015-10-132015-11-194

Filings

22
FiledFilingRegistrationAccession
2025-11-03S-3ASRShelf registered 333-2912280001193125-25-262696
2023-06-29424B5Shelf takedown 333-2686640000950170-23-030499
2023-06-28424B5Shelf takedown 333-2686640000950170-23-030261
2022-12-02S-3ASRShelf registered 333-2686640001564590-22-038976
2022-08-22424B5Shelf takedown 333-2353720001193125-22-225572
2022-03-01424B5Shelf takedown 333-2353720000950170-22-002581
2019-12-20424B5Shelf takedown 333-2353720001558370-19-011631
2019-12-18424B5Shelf takedown 333-2353720001558370-19-011587
2019-12-05S-3ASRShelf registered 333-2353720001558370-19-011368
2019-05-09424B5Shelf takedown 333-2148590001558370-19-004723
2018-09-28424B5Shelf takedown 333-2148590001104659-18-059464
2017-12-04424B5Shelf takedown 333-2148590001047469-17-007419
2017-10-20424B5Shelf takedown 333-2148590001047469-17-006481
2017-03-21424B5Shelf takedown 333-2148590001047469-17-001842
2017-03-20424B5Shelf takedown 333-2148590001047469-17-001801
2016-12-16EFFECTDeclared effective 333-2148599999999995-16-006481
2016-12-01S-3Shelf registered 333-2148590001104659-16-160116
2015-11-19EFFECTDeclared effective 333-2073939999999995-15-003096
2015-11-19424B4Final prospectus 333-2073930001047469-15-008821
2015-11-02S-1/AAmendment 333-2073930001047469-15-008199
2015-10-13S-1Registration filed 333-2073930001047469-15-007821
2015-08-25DRSDraft made public 377-011250000912057-15-000280

All filings of this company · CSV